Tracking of Stem Cells for Treatment in Cardiovascular Disease

심혈관계 질환의 줄기세포 치료에서 세포 추적 영상

  • Kang, Won-Jun (Department of Nuclear Medicine, Seoul National University College of Medicine)
  • 강원준 (서울대학교 의과대학 핵의학교실)
  • Published : 2005.04.30

Abstract

Various stem cells or progenitor cells are being used to treat cardiovascular disease in ischemic heart disease, stem ceil therapy is expected to regenerate damaged myocardium. To evaluate effects of stem cell treatment, the method to image stem cell location, distribution and differentiation is necessary. Optical imaging, MRI, nuclear imaging methods have been used for tracking stem cells. The methods and proglems of each imaging technique are reviewed.

Keywords

References

  1. Lee MS, Makkar RR. Stem-cell transplantation in myocardial infarction: a status report. Ann Intern Med 2004;140:729-37 https://doi.org/10.7326/0003-4819-140-9-200405040-00013
  2. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751-6 https://doi.org/10.1016/S0140-6736(04)15689-4
  3. Perin EC, Dohmann HF, Borojevic R, Silvar SA, Sousa AL, Silva GV, et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 2004;110:II213-8
  4. Wolbert KC, Meyer GP, Lotz J, Ringes-Lichtengerg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction;the BOOST randomized controlled trial. Lancet 2004;364:141-8 https://doi.org/10.1016/S0140-6736(04)16626-9
  5. Bittner RE, Schofer C, Weipoltshammer K, Ivanova S, Streubel B, Hauser E, et al. Recruitment of bone-marrow-derived cells by skeletal and cariac muscle in adult dystrophic mdx mice. Anat, Embryol 1999;199:391-6 https://doi.org/10.1007/s004290050237
  6. Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, HEscheler J, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat.Med 2004;10:494-501 https://doi.org/10.1038/nm1040
  7. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocyts. J Clin Invest 2001;108:407-14
  8. Zeiher AM. Peipheral blood progenitors for cardiac repair. Heart Failure Symposium. 654 J Am Coll Cardiol 2004. 268 (Abstract)
  9. Hagege AA, Carrion C, Menasche P, Vilquin JT, Duboc D, Marolleau JP, et al. Viability and differentiation of autologous skeletal myoblast grafts in ischemic cardiomyopathy. Lancet 2003;361:491-2 https://doi.org/10.1016/S0140-6736(03)12458-0
  10. Wang X, Rosol M, Ge S, McNamara G, Pollack H, Kohn DB, et al. Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging. Blood 2003;102:3478-82 https://doi.org/10.1182/blood-2003-05-1432
  11. Cao YA, Wagers AJ, Beilhack A, Dusich J, Bachmann MH, Negrin RS, et al. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A 2004;101:221-226
  12. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003;228:480-7 https://doi.org/10.1148/radiol.2281020638
  13. van den Bos EJ, Wagner A, Mahrholdt H, Thompson RB, Morimoto Y, Sutton BS, et al. Improved efficacy of stem cell labeling for magnetic resonance imaging studies by the use of cationic liposomes. Cell Transplant 2003;12:743-56
  14. Aicher A, Brenner W, Zuhayra M, Badorff C, Massoudi S, Assmus B ,et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003;107:2134-9 https://doi.org/10.1161/01.CIR.0000062649.63838.C9
  15. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, et al. Systemic delivery of bone marrowderived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003;108:863-8 https://doi.org/10.1161/01.CIR.0000084828.50310.6A
  16. Chin BB, Nakamoto Y, Bulte JW, Pittenger MF, Wahl R, Kraitchman DL. 111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl Med Commun 2003;24:1149-54 https://doi.org/10.1097/00006231-200311000-00005
  17. Gambhir SS, Herschman HR, Cherry SR, Barrio JR, Satyamurthy N, Toyokuni T, et al. Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2000;2:118-38 https://doi.org/10.1038/sj.neo.7900083
  18. Tjuvajev JG, Avril N, Oku T, Sasajima T, Miyagawa T, Joshi R, et al. Imaging herpes virus thymidine kinase gene transfer and expression by positro emission tomography. Cancer Res 1998;58: 4333-41
  19. Liang Q, Satyamurthy N, Barrio JR, Toyokuni T, Phelps MP, Gambhier SS, et al. Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene i which ligand binding is uncoupled from signal transduction. Gene Ther 2001;8:1490-200 https://doi.org/10.1038/sj.gt.3301542
  20. Chung JK. Sodium iodide symporter: Its role in nuclear medicine. J Nucl Med 2002;43:1188-200
  21. Tamura M, Unno K, Yonezawa S, Hattori K, Nakashima E, Tsukada H, et al. Life Sciences 2004;75:575-84 https://doi.org/10.1016/S0024-3205(04)00287-5
  22. Kang WJ, Lee DS, Kim H-S, Kang H-J, Hong MK, Eo JS, et al. Assessment of tissue distribution of F-18 FDG labeled hematopoietic stem cell after intracoronary administration in patients with myocardial infarction. J Nucl Med 2005 (Abstract, in press)